CVS Health (NYSE: CVS) reported Q3 EPS of $1.97, $0.20 better than the analyst estimate of $1.77. Revenue for the quarter came in at $73.79 billion versus the consensus estimate of $70.4 billion.

GUIDANCE:

CVS Health sees FY2021 EPS of $7.90-$8.00, versus the consensus of $7.79.

For earnings history and earnings-related data on CVS Health (CVS) click here.